4//SEC Filing
Hall Christopher M 4
Accession 0001384101-19-000054
CIK 0001384101other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:30 PM ET
Size
17.7 KB
Accession
0001384101-19-000054
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Hall Christopher M
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2019-05-06$8.86/sh+42,748$378,747→ 71,462 total - Sale
Common Stock
2019-05-06$25.44/sh−86,220$2,193,273→ 28,714 total - Exercise/Conversion
Stock Option (right to buy)
2019-05-06−8,506→ 82,688 totalExercise: $5.98Exp: 2028-03-01→ Common Stock (8,506 underlying) - Exercise/Conversion
Common Stock
2019-05-06$6.45/sh+63,746$411,162→ 135,208 total - Sale
Common Stock
2019-05-06$24.72/sh−28,780$711,442→ 114,934 total - Exercise/Conversion
Stock Option (right to buy)
2019-05-06−42,748→ 37,252 totalExercise: $8.86Exp: 2025-03-01→ Common Stock (42,748 underlying) - Exercise/Conversion
Common Stock
2019-05-06$5.98/sh+8,506$50,866→ 143,714 total - Exercise/Conversion
Stock Option (right to buy)
2019-05-06−63,746→ 21,254 totalExercise: $6.45Exp: 2026-02-28→ Common Stock (63,746 underlying)
Footnotes (6)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $24.00 to $24.98. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F3]Represents weighted average sales price. Sale prices for the transactions range from $25.00 to $25.82. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F4]The option is fully vested.
- [F5]The option became exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- [F6]The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
Documents
Issuer
VERACYTE, INC.
CIK 0001384101
Entity typeother
Related Parties
1- filerCIK 0001449535
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:30 PM ET
- Size
- 17.7 KB